NEW YORK, Dec 27 (Reuters) - A U.S. appeals court on Friday revived a whistleblower lawsuit accusing Swiss drugmaker Novartis (NOVN.S), opens new tab of paying illegal kickbacks to doctors to ...

Rapt Therapeutics has charted a new course following the implosion of its lead program, agreeing to pay $35 million for a long-acting challenger to Novartis and Roche’s Xolair. A deal with ...

Novartis is closing the German biotech company Morphosys, acquired earlier this year, according to German press reports confirmed by the Basel-based pharmaceutical giant. Hundreds of jobs are ...

In a move that follows an increasingly common trend in biopharma M&A, Novartis is shedding sites and staffers from the German cancer biotech it acquired earlier this year. Novartis confirmed ...

ZURICH (Reuters) -Swiss pharmaceutical group Novartis (NVS) said on Thursday it was winding up MorphoSys sites in Germany and the United States, affecting 330 jobs. Novartis had acquired MorphoSys ...

Swiss pharmaceutical company Novartis plans to close MorphoSys sites in the U.S. and Germany in a “strategic decision” that will affect 330 jobs. The move, which was first reported by the German ...

Novartis is closing down sites in Germany and Boston that were picked up in its $2.9 billion acquisition of MorphoSys, Reuters reported Thursday. The move will result in layoffs affecting 330 jobs. A ...

Credit: Dragana Gordic/Shutterstock. BioAge Labs has entered a multi-year research partnership with Novartis to discover and validate new therapeutic drug targets that address ageing-related diseases.

BioAge Labs, which be­gan near­ly a decade ago as an an­ti-ag­ing biotech and then turned to obe­si­ty this year, is go­ing back to its roots … ...

Freshly public BioAge Labs has secured a multiyear partnership with Novartis that focuses on age-related diseases and includes the possibility of up to $550 million in biobucks. The freshly inked ...

In this article, we are going to take a look at where Novartis AG (NYSE:NVS) stands against the other oversold global stocks. 'There are decades where nothing happens, and there are weeks where ...

Collaboration will leverage BioAge’s differentiated human longevity data and platform and Novartis expertise in the biology of physical exercise to identify drug targets to treat diseases related to ...